文献速递急性肾损伤慢性肾脏病

新型金铂纳米颗粒作为广谱抗氧化剂减轻肾脏缺血再灌注损伤

Novel gold-platinum nanoparticles serve as broad-spectrum antioxidants for attenuating ischemia reperfusion injury of the kidney.
PubMed 文献 · Kidney Int · 2022-07-21

本文报道一步法合成金铂纳米颗粒(AuPt NPs),其具有金核与疏松分支状铂外壳,具备过氧化氢酶和过氧化物酶样活性,可清除活性氧。体外和体内实验显示该颗粒能抑制细胞凋亡、炎症因子释放和炎症小体形成,减轻肾脏缺血再灌注损伤且无明显毒性,长期还可减少肾脏纤维化,可能成为肾脏缺血再灌注损伤的治疗剂。

要点

  • AuPt NPs具有过氧化氢酶和过氧化物酶样活性,可清除活性氧。
  • AuPt NPs在体外和体内减轻肾脏缺血再灌注损伤且无明显毒性。
  • AuPt NPs长期可减少肾脏纤维化,抑制向慢性肾脏病转化。

核心结论

  • AuPt NPs可能是肾脏缺血再灌注损伤管理的良好治疗剂,并可能有助于临床治疗的发展。

研究设计与样本

  • 本文为实验研究,报道一步法合成金铂纳米颗粒(AuPt NPs),并进行体外和体内实验评估其抗氧化和肾脏保护作用。

主要发现

  • AuPt NPs具有金核和疏松分支状铂外壳,同时具有过氧化氢酶样和过氧化物酶样活性。
  • AuPt NPs在体外和体内通过抑制细胞凋亡、炎症因子释放和炎症小体形成减轻肾脏缺血再灌注损伤,且无明显毒性。
  • AuPt NPs长期可减少肾脏纤维化,抑制向慢性肾脏病转化。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Kidney ischemia reperfusion injury (IRI) is a common and inevitable pathological condition in routine urological practices, especially during transplantation. Severe kidney IRI may even induce systemic damage to peripheral organs, and lead to multisystem organ failure. However, no standard clinical treatment option is currently available. It has been reported that kidney IRI is predominantly associated with abnormally increased endogenous reactive oxygen species (ROS). Scavenging excessive ROS may reduce the damage caused by oxidative stress and subsequently alleviate kidney IRI. Here, we reported a simple and efficient one-step synthesis of gold-platinum nanoparticles (AuPt NPs) with a gold core having a loose and branched outer platinum shell with superior ROS scavenging capacity to possibly treat kidney IRI. These AuPt NPs exhibited multiple enzyme-like anti-oxidative properties simultaneously possessing catalase- and peroxidase-like activity. These particles showed excellent cell protective capability, and alleviated kidney IRI both in vitro and in vivo without obvious toxicity, by suppressing cell apoptosis, inflammatory cytokine release, and inflammasome formation. Meanwhile, AuPt NPs also had an effect on inhibiting the transition to chronic kidney disease by reducing kidney fibrosis in the long term. Thus, AuPt NPs might be a good therapeutic agent for kidney IRI management and may be helpful for the development of clinical treatments for kidney IRI.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Feng S, Qu Y, Chu B, et al. Novel gold-platinum nanoparticles serve as broad-spectrum antioxidants for attenuating ischemia reperfusion injury of the kidney. Kidney Int. 2022. PMID: 35870640. doi:10.1016/j.kint.2022.07.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。